NMB Therapeutics, Inc — Form D
NMB Therapeutics, Inc of HEMPSTEAD, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-06. The offering totals $200K, of which $60K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-10-06
- Form: D
- Accession: 0001886659-21-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $200K
- Amount sold: $60K
- Remaining: $140K
- Investors: 1
- Date of first sale: 2021-09-27
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-415938
Issuer
- Name: NMB Therapeutics, Inc
- CIK: 0001886659
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Address: 395 WESTBURY BLVD, HEMPSTEAD, NY, 11550
- Phone: 6466448760
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Melvin Ehrlich | Director | Roslyn Harbor, NY |
| Daniel Fisher | Director | Pleasant Hill, CA |
| Melvin Ehrlich | Executive Officer | Roslyn Harbor, NY |
| Daniel Fisher | Executive Officer | Pleasant Hill, CA |
| Murray Froikin | Executive Officer | New York, NY |
More